BR112023019022A2 - Bloqueadores de kv1.3 - Google Patents
Bloqueadores de kv1.3Info
- Publication number
- BR112023019022A2 BR112023019022A2 BR112023019022A BR112023019022A BR112023019022A2 BR 112023019022 A2 BR112023019022 A2 BR 112023019022A2 BR 112023019022 A BR112023019022 A BR 112023019022A BR 112023019022 A BR112023019022 A BR 112023019022A BR 112023019022 A2 BR112023019022 A2 BR 112023019022A2
- Authority
- BR
- Brazil
- Prior art keywords
- blockers
- producing
- methods
- present
- polynucleotides encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
- C07K14/43522—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from scorpions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Insects & Arthropods (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21164384 | 2021-03-23 | ||
| EP21213431 | 2021-12-09 | ||
| PCT/EP2022/057533 WO2022200374A1 (en) | 2021-03-23 | 2022-03-22 | Kv1.3 blockers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023019022A2 true BR112023019022A2 (pt) | 2023-10-17 |
Family
ID=80952156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023019022A BR112023019022A2 (pt) | 2021-03-23 | 2022-03-22 | Bloqueadores de kv1.3 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240182531A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4314024A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511449A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230159403A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022245193A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023019022A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3208713A1 (cg-RX-API-DMAC7.html) |
| CL (1) | CL2023002590A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL305219A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023010930A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202304957A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022200374A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4604984A1 (en) * | 2022-10-18 | 2025-08-27 | Zealand Pharma A/S | Inhibitors |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ295838B6 (cs) | 1996-09-09 | 2005-11-16 | Zealand Pharma A/S | Způsob výroby peptidů |
| GB0414272D0 (en) | 2004-06-25 | 2004-07-28 | Cellpep Sa | OsK1 derivatives |
| EP2474316B1 (en) | 2004-10-07 | 2016-04-06 | The Regents of The University of California | Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels |
| US7833979B2 (en) | 2005-04-22 | 2010-11-16 | Amgen Inc. | Toxin peptide therapeutic agents |
| PE20081140A1 (es) | 2006-10-25 | 2008-09-22 | Amgen Inc | Agentes terapeuticos a base de peptidos derivados de toxinas |
| US8429751B2 (en) | 2009-03-13 | 2013-04-23 | Trustwave Holdings, Inc. | Method and apparatus for phishing and leeching vulnerability detection |
| NZ709913A (en) | 2013-01-25 | 2019-05-31 | Janssen Biotech Inc | Kv1.3 antagonists and methods of use |
| JP2016527250A (ja) | 2013-07-22 | 2016-09-08 | キネタ ワン リミテッド ライアビリティ カンパニーKineta One,Llc | 毒素系治療用ペプチド及びその医薬組成物の眼科的使用 |
| US20180264080A1 (en) | 2015-01-09 | 2018-09-20 | Kineta One, Llc | TOPICAL APPLICATIONS OF Kv1.3 CHANNEL BLOCKING PEPTIDES TO TREAT SKIN INFLAMMATION |
| EP4031162A1 (en) * | 2019-09-20 | 2022-07-27 | Zealand Pharma A/S | Kv1.3 blockers |
-
2022
- 2022-03-22 IL IL305219A patent/IL305219A/en unknown
- 2022-03-22 US US18/282,566 patent/US20240182531A1/en active Pending
- 2022-03-22 MX MX2023010930A patent/MX2023010930A/es unknown
- 2022-03-22 EP EP22712949.1A patent/EP4314024A1/en active Pending
- 2022-03-22 JP JP2023558496A patent/JP2024511449A/ja active Pending
- 2022-03-22 BR BR112023019022A patent/BR112023019022A2/pt unknown
- 2022-03-22 AU AU2022245193A patent/AU2022245193A1/en active Pending
- 2022-03-22 KR KR1020237030953A patent/KR20230159403A/ko active Pending
- 2022-03-22 CA CA3208713A patent/CA3208713A1/en active Pending
- 2022-03-22 WO PCT/EP2022/057533 patent/WO2022200374A1/en not_active Ceased
- 2022-03-23 TW TW111110743A patent/TW202304957A/zh unknown
-
2023
- 2023-08-31 CL CL2023002590A patent/CL2023002590A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20240182531A1 (en) | 2024-06-06 |
| CA3208713A1 (en) | 2022-09-29 |
| EP4314024A1 (en) | 2024-02-07 |
| JP2024511449A (ja) | 2024-03-13 |
| CL2023002590A1 (es) | 2024-03-15 |
| AU2022245193A1 (en) | 2023-09-07 |
| IL305219A (en) | 2023-10-01 |
| WO2022200374A1 (en) | 2022-09-29 |
| KR20230159403A (ko) | 2023-11-21 |
| TW202304957A (zh) | 2023-02-01 |
| MX2023010930A (es) | 2023-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022004927A2 (pt) | Bloqueadores de kv1.3 | |
| UY39798A (es) | Anticuerpos anti-ccr8 y usos de los mismos | |
| CL2021002880S1 (es) | Estuche de auriculares. (divisional solicitud 202000595) | |
| CO2021008980A2 (es) | Sistemas activos dinámicos acromosómicos | |
| ECSP21073266A (es) | Compuestos, composiciones y métodos para el tratamiento de enfermedad | |
| BR112022018678A2 (pt) | Degradadores de mdm2 e usos dos mesmos | |
| MX2022007841A (es) | Degradadores del regulador dependiente de actina asociado a la matriz relacionado con el complejo switch/sacarosa no fermentable de la subfamilia a de la cromatina (smarca)y usos de los mismos. | |
| BR112023023223A2 (pt) | Degradadores de cdk2 e usos dos mesmos | |
| MX2021014197A (es) | Mecanismos de ajuste de altura, profundidad y circunferencial para collarin cervical. | |
| BR112022012920A2 (pt) | Instrumento cirúrgico compreendendo um sistema de ajuste | |
| AR120883A1 (es) | Anticuerpos anti-fgfr2b | |
| AR120886A1 (es) | Anticuerpos anti-fgfr2b | |
| CL2021000232S1 (es) | Parte de afeitadora. | |
| BR112022014399A2 (pt) | Método de processamento de recurso de domínio de frequência, método de configuração de recurso de domínio de frequência e dispositivo relacionado | |
| BR112023024837A2 (pt) | Anticorpos anti-ccr8 | |
| CL2023003696A1 (es) | Anticuerpos anti-pcrv que se unen a pcrv, composiciones que comprenden anticuerpos anti-pcrv, métodos de uso | |
| CL2020001197A1 (es) | Combinación novedosa de defoliantes. | |
| MX2021010254A (es) | Conjugados de anticuerpo-farmaco que comprenden anticuerpos anti-tm4sf1 y metodos de uso de los mismos. | |
| AR123432A1 (es) | Concentrado de cannabinoides libre de thc, método de obtención del mismo y su uso | |
| BR112022021077A2 (pt) | Anticorpos humanizados antifator bb de complemento e uso dos mesmos | |
| CL2023002590A1 (es) | Bloqueadores de kv1.3 | |
| CL2021002501A1 (es) | Compuestos novedosos y métodos de uso de los mismos. | |
| CL2024000333A1 (es) | Vacuna de clostridium chauvoei y métodos para producirla | |
| EA202191565A1 (ru) | Способ получения циклического динуклеотида | |
| CO2022018892A2 (es) | Procedimiento de preparación de la diosmina |